Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Read about how Oxford's experts are leading the way in cancer prevention, detection and treatment as part of the University's Cancer at Oxford series

Cancer kills nearly 10 million people worldwide per year. Half of us in the UK will have cancer in our lifetime.

Whether environmental or genetic, modifiable or unavoidable, researchers at Oxford are uncovering the causes of cancer. Oxford is leading the drive to detect cancer earlier, using big data to revolutionise cancer research and innovating with AI to improve diagnosis.

Our experts are also turning immune systems against tumours, creating vaccines against cancer and improving the outcomes for cancer patients worldwide by developing new therapies and improving existing ones.

We’re building on historic Oxford cancer breakthroughs, working with partners locally, nationally and globally to turn Oxford discoveries into life-saving realities.

Visit the Cancer at Oxford website to read about just some of the stories behind the research.

Similar stories

Dr Brian Nicholson reacts to news that GPs in England will have direct access to book cancer tests for their patients

This initiative, announced by the NHS England Chief Executive, is part of the drive to diagnose cancers earlier in the NHS by “fast-tracking” community-based diagnostic testing.

Assessing a combined approach for risk-stratified population screening for colorectal cancer

Polygenic risk scores only modestly improve the predictive power of the QCancer-10 non-genetic risk score for colorectal cancer